KIAA0101-TRIP4 Fusion FISH Probe
The KIAA0101-TRIP4 Fusion FISH Probe is used to confirm a fusion of the KIAA0101 and TRIP4 genes. The fusion of the KIAA0101 and TRIP4 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| KIAA0101-TRIP4-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-RERE | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-REOR | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-REGO | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-REGR | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-OROR | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-GORE | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-GROR | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| KIAA0101-TRIP4-20-AQAQ | 20 (40 μL) | 200 μL |
|
TRIP4 Gene Summary
This gene encodes a subunit of the tetrameric nuclear activating signal cointegrator 1 (ASC-1) complex, which associates with transcriptional coactivators, nuclear receptors and basal transcription factors to facilitate nuclear receptors-mediated transcription. This protein is localized in the nucleus and contains an E1A-type zinc finger domain, which mediates interaction with transcriptional coactivators and ligand-bound nuclear receptors, such as thyroid hormone receptor and retinoid X receptor alpha, but not glucocorticoid receptor. Mutations in this gene are associated with spinal muscular atrophy with congenital bone fractures-1 (SMABF1). [provided by RefSeq, Apr 2016]
Gene Name: Thyroid Hormone Receptor Interactor 4
Chromosome: CHR15: 64680002 -64747502
Locus: 15q22.31
Gene Diseases
The KIAA0101 TRIP4 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|